Wipfli Financial Advisors’s Fulgent Genetics FLGT Stock Holding History

Wipfli Financial Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$17K	Buy	+447	New	+$22.4K	﹤0.01%	1627

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wipfli Financial Advisors's FLGT Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Fulgent Genetics (FLGT) in Q3 2022: 447 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #1627 among its holdings.

235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

Wipfli Financial Advisors held 447 shares of Fulgent Genetics worth $17K as of Q3 2022.
Fulgent Genetics was a new Wipfli Financial Advisors position in Q3 2022.
Fulgent Genetics made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1627 holding.
235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.